Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - codeine phosphate - oral tablet - 60mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - codeine phosphate - oral tablet - 30mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - codeine phosphate - oral tablet - 30mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - codeine phosphate - oral tablet - 60mg

Australija - engleski - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid - excipient ingredients: glycerol; propylene glycol; purified water; sucrose; methyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu relief of unproductive, dry and intractable coughs associated with colds and flu.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: potassium sorbate; maize starch; povidone; purified talc; stearic acid; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch - paracetamol/codeine gh 500/30 is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Kanada - engleski - Health Canada

laboratoire atlas inc - codeine phosphate - syrup - 25mg - codeine phosphate 25mg - opiate agonists

Kanada - engleski - Health Canada

sandoz canada incorporated - codeine phosphate - liquid - 30mg - codeine phosphate 30mg - opiate agonists

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - codeine phosphate 10 mg in 5 ml - promethazine with codeine syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age. concomitant administration of promethazine products with other respiratory depressants has an association with resp

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

northwind pharmaceuticals - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - codeine phosphate 30 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] have not provided adequate analgesia, or are not expected to provide adequate analgesia have not been tolerated, or are not expected to be tolerated please review the manufacturer's complete drug information available from the fda at www.fda.gov permanent link: https://dailymed.nlm.nih.gov/dailymed/druginfo.cfm?setid=02386806-02d4-47e3-9c8b-7810146ee795 acetaminophen and codeine phosphate tablets are contraindicated in patients with: patients with significant respiratory depression [see warnings].